EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances and Challenges in Pluripotent Stem Cell‐Based Whole‐Cell Vaccines for Cancer Treatment

Guoyue Wan, Jian‐Dong Huang, Ren‐He Xu, Meiling Jin

Medicine Bulletin · 2025-06 · 1 (1) · 60-76

DOI: 10.1002/mdb2.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine Bulletin, online erschienen am 11.06.2025. Verfasst von Guoyue Wan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, an unexpected application of pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), as a novel source for whole‐cell vaccines (WCVs) against cancer has attracted attention in the field of tumor immunotherapy. WCVs utilize entire cells as a source of antigens capable of activating various immune responses, including both cellular and humoral immunity. Traditional WCVs typically employ inactivated or genetically modified tumor cells to stimulate the immune system and induce tumor‐specific immune responses. Since we first reported in 2009, it has been gradually recognized that the immunogenicity and multi‐target potential of PSCs make them an ideal vaccine platform. Although WCVs are still associated with challenges such as ethical concerns, poor immunogenicity, and insufficient immune stimulation, it has become clear that PSC‐based anticancer vaccines contain tumor‐associated antigens. These vaccines can be delivered in various forms, including cell membrane fusion, stem cell outer membrane vesicles (OMVs), and cryopreserved whole‐cell vaccines. Our review aims to summarize the history and status of PSC vaccines, including adjuvant selection, cell‐free vaccines, and mechanisms of action for PSC vaccines. We also discuss challenges and perspectives in this line of research.

Zitieren

APA

Wan, G., Huang, J., Xu, R., & Jin, M. (2025). Advances and Challenges in Pluripotent Stem Cell‐Based Whole‐Cell Vaccines for Cancer Treatment. Medicine Bulletin, 1(1), 60-76. https://doi.org/10.1002/mdb2.70002

Vancouver

Wan G, Huang J, Xu R, Jin M. Advances and Challenges in Pluripotent Stem Cell‐Based Whole‐Cell Vaccines for Cancer Treatment. Medicine Bulletin. 2025;1(1):60-76. doi:10.1002/mdb2.70002

BibTeX
@article{Wan2025,
  author = {Wan, Guoyue and Huang, Jian‐Dong and Xu, Ren‐He and Jin, Meiling},
  title = {Advances and Challenges in Pluripotent Stem Cell‐Based Whole‐Cell Vaccines for Cancer Treatment},
  journal = {Medicine Bulletin},
  year = {2025},
  volume = {1},
  number = {1},
  pages = {60--76},
  doi = {10.1002/mdb2.70002}
}
Kostenlos starten →